The phase 1/2 Mobilize trial is evaluating the safety and efficacy of mRNA-4359
Category: News
The platform delivers digitalised patient data to improve clinical trials and development
The chip removes cells, which could become tumours, before they are implanted in a patient
OART is increasingly emerging to assess and adapt treatment for cancer patients
The rare neurodevelopmental condition CDKL5 is characterised by early-onset epilepsy
The cell could be a target for new immunotherapies for the chronic disease
The committee has advised that the vaccine should be given to those at the highest risk
The new products are in the areas of gastrointestinal and respiratory medicines
The HTA reported that Brainomix 360 improved access to treatment for stroke patients
Hypoxic-ischaemic encephalopathy affects around three million babies worldwide every year